Recurrent Depression
Mental Health
Recurrent Depression is treated with 10 medications in our database, including Fluoxetine, escitalopram oxalate, vilazodone, Vilazodone, paroxetine hydrochloride, Bupropion Hydrochloride (SR), and 5 more. 7 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Eli Lilly, Lundbeck, AbbVie, GlaxoSmithKline, Pfizer and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Recurrent Depression treatment below.
What help exists for Recurrent Depression
9
drugs indexed
4
with copay cards
4
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Recurrent Depression
9 totalFluoxetine
Fluoxetine Hydrochloride · Eli Lilly
BUPROPION HYDROCHLORIDE SR
bupropion hydrochloride · GlaxoSmithKline
Vilazodone Hydrochloride
vilazodone hydrochloride · AbbVie
🎟💙vilazodone, Vilazodone
AbbVie
🎟💙Aplenzin
bupropion hydrobromide · Bausch Health
🎟💙Escitalopram Oxalate
Escitalopram Oxalate · Lundbeck
BUPROPION HYDROCHLORIDE (SR)
Bupropion hydrochloride · GlaxoSmithKline
Desvenlafaxine Succinate
desvenlafaxine succinate · Pfizer
🎟💙Paroxetine Hydrochloride
paroxetine hydrochloride · GlaxoSmithKline
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Recurrent Depression drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Showing 10 of 21 PA rules for Recurrent Depression drugs. View individual drug pages for complete PA detail.